Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.8%

4 terminated/withdrawn out of 228 trials

Success Rate

94.8%

+8.3% vs industry average

Late-Stage Pipeline

13%

30 trials in Phase 3/4

Results Transparency

0%

0 of 73 completed trials have results

Key Signals

37 recruiting

Enrollment Performance

Analytics

N/A
76(45.0%)
Phase 2
36(21.3%)
Phase 1
21(12.4%)
Phase 4
18(10.7%)
Phase 3
12(7.1%)
Early Phase 1
6(3.6%)
169Total
N/A(76)
Phase 2(36)
Phase 1(21)
Phase 4(18)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (228)

Showing 20 of 228 trials
NCT05965687Phase 3Completed

Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke (OPENS-3)

Role: collaborator

NCT06331923Not ApplicableCompleted

Assessing the Effectiveness of Continuous Glucose Monitoring in Enhancing Surgical Outcomes for Patients With Diabetes

Role: collaborator

NCT07724210Not ApplicableNot Yet Recruiting

Effectiveness of Digital Defocus Vision Training With Low-Concentration Atropine on the Prevention and Control of Myopia in Children: A Clinical Study

Role: lead

NCT07709832Not ApplicableNot Yet Recruiting

A Randomized Controlled Trial of Autostereoscopic 3D Vision Therapy for Amblyopia

Role: lead

NCT07703449Not ApplicableCompleted

Research and Development of Reading Visual Aids for Low-Vision Individuals Based on Virtual Reality Technology

Role: lead

NCT03944239Phase 1Active Not Recruiting

Safety and Efficacy of Subretinal Transplantation of Clinical Human Embryonic Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Retinitis Pigmentosa

Role: collaborator

NCT07679685Phase 4Not Yet Recruiting

Perfluorohexyloctane Eye Drops vs. Sodium Hyaluronate for Video Display Terminal-Associated Dry Eye

Role: lead

NCT07672639Completed

Development and Validation of a Machine Learning Model for Differentiating Diabetic Kidney Disease and Non-Diabetic Kidney Disease in Type 2 Diabetes

Role: lead

NCT05846217Not ApplicableCompleted

Bell's Palsy With a Duration of Greater Than 8 Weeks Treated With Multiwave Locked System Intervention

Role: lead

NCT07201493Not ApplicableCompleted

Evaluation of New Color Temperature Adjustment Mode in Preventing Dry Eye and Visual Fatigue

Role: lead

NCT07616609Not ApplicableNot Yet Recruiting

Preoperative Stapokibart for Endoscopic Sinus Surgery in Chronic Rhinosinusitis With Nasal Polyps

Role: lead

NCT07597395Phase 3Not Yet Recruiting

ATRA for Management of Primary ITP

Role: collaborator

NCT07040072Phase 1Recruiting

Finotonlimab Combined With Stapokibart in the Treatment of Recurrent/Metastatic HNSCC

Role: lead

NCT07291960Not Yet Recruiting

Retinal Clinical Assessment With AI-derived Quantitative Information

Role: lead

NCT07554482Phase 2Not Yet Recruiting

Selinexor Combined With Reduced-Dose Radiotherapy For Early-Stage Extranodal NK/T-Cell Lymphoma

Role: lead

NCT06140992Recruiting

PaCIFiC-CUP Classifies Cancer of Unknown Primary

Role: collaborator

NCT07461831Phase 2Active Not Recruiting

CD19/ CD22 Bispecific CAR-T Cell Therapy for Relapsed/ Refractory Large B-cell Lymphoma

Role: lead

NCT07523737Phase 2Recruiting

Pomalidomide, Anti-PD-1 Antibody Combined With Selinexor (PPS) in Relapsed/Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma

Role: lead

NCT07525466Phase 1Recruiting

Combination of Mitoxantrone Liposome and Etoposide, Dexamethasone, Pegaspargase and Golidocitinib (MEPL-G) in the Treatment of NK/T-cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis (NKTCL-HLH)

Role: lead

NCT07524959Not ApplicableNot Yet Recruiting

Antagonism of Neostigmine in Continuous Infusion of Mivacurium

Role: lead